Compare Dr. Reddys with AJANTA PHARMA - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. REDDYS LAB vs AJANTA PHARMA - Comparison Results

DR. REDDYS LAB     Change

Dr. Reddy's is a leading pharmaceutical company in the country with presence across the pharmaceutical value chain - basic research, finished dosages, generics, bulk actives, and biotechnology. The company's business is mainly organized into Global g... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR. REDDYS LAB AJANTA PHARMA DR. REDDYS LAB/
AJANTA PHARMA
 
P/E (TTM) x 34.8 24.7 141.1% View Chart
P/BV x 4.8 6.9 69.5% View Chart
Dividend Yield % 0.6 0.5 108.4%  

Financials

 DR. REDDYS LAB   AJANTA PHARMA
EQUITY SHARE DATA
    DR. REDDYS LAB
Mar-20
AJANTA PHARMA
Mar-19
DR. REDDYS LAB/
AJANTA PHARMA
5-Yr Chart
Click to enlarge
High Rs3,3631,422 236.5%   
Low Rs2,352898 262.0%   
Sales per share (Unadj.) Rs1,054.2233.5 451.4%  
Earnings per share (Unadj.) Rs121.944.0 277.3%  
Cash flow per share (Unadj.) Rs190.252.2 364.7%  
Dividends per share (Unadj.) Rs25.009.00 277.8%  
Dividend yield (eoy) %0.90.8 112.7%  
Book value per share (Unadj.) Rs938.7255.1 368.0%  
Shares outstanding (eoy) m166.1788.02 188.8%   
Bonus/Rights/Conversions ESOPBB-  
Price / Sales ratio x2.75.0 54.6%   
Avg P/E ratio x23.426.4 88.8%  
P/CF ratio (eoy) x15.022.2 67.6%  
Price / Book Value ratio x3.04.5 67.0%  
Dividend payout %20.520.5 100.2%   
Avg Mkt Cap Rs m474,831102,081 465.2%   
No. of employees `00021.76.8 318.4%   
Total wages/salary Rs m33,8024,307 784.8%   
Avg. sales/employee Rs Th8,091.03,022.6 267.7%   
Avg. wages/employee Rs Th1,561.3633.4 246.5%   
Avg. net profit/employee Rs Th935.8569.1 164.4%   
INCOME DATA
Net Sales Rs m175,17020,554 852.3%  
Other income Rs m6,206211 2,944.0%   
Total revenues Rs m181,37620,765 873.5%   
Gross profit Rs m24,4215,664 431.1%  
Depreciation Rs m11,348721 1,574.4%   
Interest Rs m98312 8,474.1%   
Profit before tax Rs m18,2965,143 355.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m5610-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-1,4031,273 -110.2%   
Profit after tax Rs m20,2603,870 523.6%  
Gross profit margin %13.927.6 50.6%  
Effective tax rate %-7.724.8 -31.0%   
Net profit margin %11.618.8 61.4%  
BALANCE SHEET DATA
Current assets Rs m125,99111,812 1,066.6%   
Current liabilities Rs m72,1413,776 1,910.3%   
Net working cap to sales %30.739.1 78.6%  
Current ratio x1.73.1 55.8%  
Inventory Days Days7377 94.4%  
Debtors Days Days10582 128.4%  
Net fixed assets Rs m83,85414,398 582.4%   
Share capital Rs m831175 473.8%   
"Free" reserves Rs m155,15722,277 696.5%   
Net worth Rs m155,98822,452 694.8%   
Long term debt Rs m1,3047 19,757.6%   
Total assets Rs m232,25326,962 861.4%  
Interest coverage x19.6444.3 4.4%   
Debt to equity ratio x00 2,843.8%  
Sales to assets ratio x0.80.8 98.9%   
Return on assets %9.114.4 63.5%  
Return on equity %13.017.2 75.4%  
Return on capital %12.623.0 55.0%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m84,19310,682 788.2%   
Fx outflow Rs m39,6162,102 1,884.8%   
Net fx Rs m44,5778,580 519.6%   
CASH FLOW
From Operations Rs m29,8413,748 796.2%  
From Investments Rs m-4,923-2,228 221.0%  
From Financial Activity Rs m-25,159-1,475 1,706.2%  
Net Cashflow Rs m-26645 -588.5%  

Share Holding

Indian Promoters % 25.5 73.8 34.6%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 5.4 1.6 348.4%  
FIIs % 35.3 7.6 464.5%  
ADR/GDR % 18.5 0.0 -  
Free float % 15.3 17.0 90.0%  
Shareholders   75,885 20,968 361.9%  
Pledged promoter(s) holding % 0.0 4.4 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR. REDDYS LAB With:   DISHMAN PHARMA  CADILA HEALTHCARE  SUVEN LIFE SCIENCES  DR. DATSONS LABS  WOCKHARDT  

Compare DR. REDDYS LAB With:   MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 441 Points Lower; Nifty Settles Below 15,000-Mark(Closing)

Indian share markets witnessed huge selling during closing hours today and ended their day lower.

Related Views on News

AJANTA PHARMA Announces Quarterly Results (3QFY21); Net Profit Up 64.2% (Quarterly Result Update)

Feb 5, 2021 | Updated on Feb 5, 2021

For the quarter ended December 2020, AJANTA PHARMA has posted a net profit of Rs 2 bn (up 64.2% YoY). Sales on the other hand came in at Rs 7 bn (up 15.0% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

AJANTA PHARMA Announces Quarterly Results (2QFY21); Net Profit Up 46.3% (Quarterly Result Update)

Nov 6, 2020 | Updated on Nov 6, 2020

For the quarter ended September 2020, AJANTA PHARMA has posted a net profit of Rs 2 bn (up 46.3% YoY). Sales on the other hand came in at Rs 7 bn (up 11.4% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

AJANTA PHARMA Announces Quarterly Results (1QFY21); Net Profit Up 28.9% (Quarterly Result Update)

Aug 24, 2020 | Updated on Aug 24, 2020

For the quarter ended June 2020, AJANTA PHARMA has posted a net profit of Rs 1 bn (up 28.9% YoY). Sales on the other hand came in at Rs 7 bn (up 9.2% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

AJANTA PHARMA Announces Quarterly Results (4QFY20); Net Profit Up 45.3% (Quarterly Result Update)

May 21, 2020 | Updated on May 21, 2020

For the quarter ended March 2020, AJANTA PHARMA has posted a net profit of Rs 1 bn (up 45.3% YoY). Sales on the other hand came in at Rs 7 bn (up 32.4% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

AJANTA PHARMA Announces Quarterly Results (3QFY20); Net Profit Up 60.8% (Quarterly Result Update)

Feb 6, 2020 | Updated on Feb 6, 2020

For the quarter ended December 2019, AJANTA PHARMA has posted a net profit of Rs 1 bn (up 60.8% YoY). Sales on the other hand came in at Rs 7 bn (up 34.2% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

More Views on News

Most Popular

It's the Beginning of a New Bull Phase in Smallcaps(Profit Hunter)

Feb 24, 2021

Last time the smallcap index crossed 19k a big correction followed. Here's what makes it different this time.

Make Rs 5,000 Per Day Trading the Market(Fast Profits Daily)

Feb 25, 2021

In this video, I'll show you how to get started on the path to daily trading profits.

The Hidden Tesla in My Great Indian Wealth Project(Profit Hunter)

Feb 23, 2021

An Indian company founded three decades ago in a garage caught my attention...

How Much Money For Day Trading?(Fast Profits Daily)

Feb 22, 2021

In this video, I'll show you how to allocate your capital as a day trader.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

DR. REDDYS LAB SHARE PRICE


Mar 5, 2021 (Close)

TRACK DR. REDDYS LAB

  • Track your investment in DR. REDDYS LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

DR. REDDYS LAB 5-YR ANALYSIS

COMPARE DR. REDDYS LAB WITH

MARKET STATS